570 Biowissenschaften; Biologie
Refine
Has Fulltext
- no (117) (remove)
Year of publication
Document Type
- Article (80)
- Doctoral Thesis (27)
- Review (5)
- Other (3)
- Habilitation Thesis (2)
Is part of the Bibliography
- yes (117)
Keywords
- FGF21 (3)
- acid sphingomyelinase (3)
- ceramide (3)
- inflammation (3)
- Insulin resistance (2)
- Mendelian randomization (2)
- Mitochondria (2)
- Nutrition (2)
- Oxidative stress (2)
- Pregnancy (2)
- adipose tissue (2)
- cancer (2)
- diet (2)
- fatty acid metabolism (2)
- gallbladder cancer (2)
- genes (2)
- insulin (2)
- lipid metabolism (2)
- liver (2)
- mitochondria (2)
- proteasome (2)
- proteostasis (2)
- sarcopenia (2)
- sphingolipids (2)
- transcriptomics (2)
- α-amylase/trypsin inhibitors (2)
- 1-Methoxy-3-indolylmethyl glucosinolate (1)
- 1-aminodecylidene bis-phosphonic acid (1)
- 1-phosphate (1)
- 20S (1)
- 2D-LC-MS/MS (1)
- 3D breast cell model (1)
- 7 macrophages (1)
- Adipocytes (1)
- Adipose tissue (1)
- Adult height (1)
- Advanced glycation endproducts (1)
- Aflatoxin B1 (1)
- African indigenous vegetables (1)
- Alternativmethoden (1)
- Amaranth (1)
- Amaranthaceae (1)
- Arsenic-containing fatty acids (1)
- Arsenic-containing hydrocarbons (1)
- Arsenolipids (1)
- Aspergillus (1)
- Astrocytes (1)
- Autophagie Lysosomale System (1)
- Autotaxin (1)
- BBsome (1)
- Bbs4 (1)
- Beryllium (1)
- Biomarker (1)
- Blood pressure (1)
- Blood protein adducts (1)
- Boron exposure (1)
- Brassica (1)
- Brassica rapa ssp. chinensis (1)
- C-reactive protein (1)
- C. elegans (1)
- CRISPR editing validation (1)
- Caco-2 intestinal barrier model (1)
- Caco-2/HT-29-MTX-model (1)
- Caenorhabditis elegans (1)
- Cancer prevention (1)
- Cardiovascular diseases (1)
- Carotenoid (1)
- Carotenoids (1)
- Cellular uptake (1)
- Cereals (1)
- Chronic diseases (1)
- Circadian rhythm (1)
- Cohort studies (1)
- Colitis ulcerosa (1)
- Complications in diabetes (1)
- Copper (1)
- DNA adducts (1)
- DNA damage (1)
- DNA damage response (1)
- DNMT inhibitor (1)
- Dendritic cells (1)
- Diabetes incidence (1)
- Drug delivery (1)
- EBI3 (1)
- Eicosanoid (1)
- Energy expenditure (1)
- Epigenetik (1)
- Epstein-Barr Virus-induziertes Gen 3 (1)
- Et-1 (1)
- Excretion (1)
- First trimester (1)
- Flavonoid (1)
- GCN2 (1)
- GDF15 (1)
- Geriatric patients (1)
- Glucosinolate breakdown product (1)
- Glycation (1)
- Gut microbiota (1)
- HPLC/HR-ESMS (1)
- HPLC/ICPMS (1)
- HRMS (1)
- Hautmodell (1)
- Heat shock protein 90 (1)
- Heme (1)
- Hepatic insulin resistance (1)
- Hepatocytes (1)
- Heterogeneity (1)
- High resolution microscopy (1)
- Hormones (1)
- Hyperglycaemia (1)
- Hypertension (1)
- In vitro blood-brain barrier model (1)
- Insulin signaling (1)
- Insulinresistenz (1)
- Intraperitoneal administration (1)
- Isoprostane (1)
- Jurkat cells (1)
- Kokultur (1)
- Kontaktallergie (1)
- Kupfferzellen (1)
- LC-MS/MS (1)
- LC–MS/MS (1)
- LEDs (1)
- LPA(3) receptor subtype (1)
- Labile zinc (1)
- Langerhans Zellen (1)
- Leg length (1)
- Light quality (1)
- Liver fat (1)
- Low birth weight (1)
- Lysophosphatidic acid (1)
- MALDI-TOF-MS (1)
- MMF (1)
- MSCs (1)
- Macrovascular (1)
- Marker (1)
- Mediterranean diet (1)
- Meta-analyses (1)
- Meta-analysis (1)
- Metabolom (1)
- Microvascular complications (1)
- Modified mycotoxins (1)
- Multi-method (1)
- Mycotoxins (1)
- Myoglobin (1)
- NAFLD (1)
- NF-kappa B (1)
- NMR-based metabolomics (1)
- NZO (1)
- Nanoparticles (1)
- Neoglucobrassicin (1)
- OCFA (1)
- Obesity (1)
- Ontogeny (1)
- Oxylipin (1)
- Pak choi (1)
- Parkinson disease (1)
- Paternal exposure (1)
- Personalised medicine (1)
- Pesticides (1)
- PlGF (1)
- Precision medicine (1)
- Precision prognostics (1)
- Prostaglandin E2 (1)
- Proteasome (1)
- Protein aggregates (1)
- Protein oxidation (1)
- Protein restriction (1)
- Proteostase (1)
- QTL (1)
- RAW 264 (1)
- RBP4 (1)
- ROS (1)
- Rats (1)
- Redox control (1)
- Resistant starch (1)
- Retinol (1)
- Review (1)
- Risk (1)
- Risk prediction (1)
- S-XRF (1)
- SDS-PAGE (1)
- SIMS techniques (1)
- ST-1893 (1)
- ST-1894 (1)
- Se-methylselenoneine (1)
- Sex ratio at birth (1)
- Short stature (1)
- Skeletal muscle cells (1)
- Skelettmuskelalterung (1)
- Skin penetration (1)
- Small for gestational age (1)
- Smpd1 (1)
- Sphingolipids (1)
- TEM (1)
- TGF-beta (1)
- TNF alpha (1)
- TTR (1)
- Tenebrio molitor larvae (1)
- Testicle (1)
- Thermal processing (1)
- Toxicity (1)
- Trace elements (1)
- Trans-epoxy-fatty acid (1)
- Transkriptom (1)
- Trunk length (1)
- Type 2 diabetes (1)
- Ubiquitin Proteasom System (1)
- Ulcerative colitis (1)
- Umbrella review (1)
- Vitamin A (1)
- WAT (1)
- Warburg effect (1)
- World Cancer Research Fund/American Institute for Cancer Research Recommendations (1)
- Y:X chromosome ratio (1)
- Zinc (1)
- Zinc homeostasis (1)
- acid ceramidase (1)
- activated carbon (1)
- adipogenesis (1)
- adiponectin (1)
- adiposity (1)
- age (1)
- ageing (1)
- aging (1)
- all-cause mortality (1)
- amaranth (1)
- amino acids (1)
- and nutrition (1)
- anorexia (1)
- anthropometric measures (1)
- antioxidative capacity (1)
- anxiety-like behavior (1)
- apoptosis (1)
- appetite regulation (1)
- aroma quality (1)
- arsenic (1)
- arsenolipids (1)
- asymmetric dimethylarginine (ADMA) (1)
- autophagy (1)
- autophagy lysosomal system (1)
- base excision repair (incision activity) (1)
- beta-carotene hydroxylase (1)
- beta-cell (1)
- bioavailability (1)
- biofortification (1)
- biomarkers of renal failure (1)
- birth weight (1)
- bisphosphonates (1)
- blood banking (1)
- brain insulin signaling (1)
- browning (1)
- caffeic acid derivatives (1)
- calcination (1)
- cancer epidemiology (1)
- cardiokine (1)
- cardiovascular diseases (1)
- carotenoid biosynthesis (1)
- carotenoids (1)
- cellular bioimaging (1)
- cerami-des (1)
- ceramides (1)
- cereal meals (1)
- cholesterol (1)
- chronic diseases (1)
- cilium (1)
- circadian clock (1)
- clusterin (1)
- coffee by-products (1)
- colorectal neoplasm (1)
- colour (1)
- complications (1)
- constitutive androstane receptor (1)
- contrast-induced nephropathy (1)
- copper (1)
- copper-related disorders (1)
- copy number analyses (1)
- cortisol (1)
- cytokine (1)
- cytokines (1)
- database (1)
- decitabine (1)
- depressive-like behavior (1)
- design of experiment (1)
- diabetes (1)
- diabetes mellitus (1)
- dietary patterns (1)
- dietary restriction (1)
- digestive enzymes quantification (1)
- disease (1)
- drug delivery (1)
- electrochemistry (1)
- endocrine disruption (1)
- enzyme induction (1)
- enzymology (1)
- epidemiology (1)
- exercise (1)
- experimental antigen-induced encephalomyelitis (1)
- fatty pancreas (1)
- feeding (1)
- fermentation (1)
- fetal origins hypothesis (1)
- food (1)
- food frequency questionnaire (1)
- forebrain (1)
- fractionation (1)
- functional inhibitors of acid sphin-gomyelinase (1)
- functional properties (1)
- gene-lifestyle interaction (1)
- glucocorticoid receptor (1)
- goblet cells (1)
- growth behavior (1)
- growth restriction (1)
- gwas (1)
- heart (1)
- homeostasis (1)
- homologous recombination deficiency (1)
- homology-directed repair (1)
- human excised skin (1)
- human liver microsomes (1)
- human milk (1)
- immune-inflammatory biomarkers (1)
- immunology (1)
- immunomodulator (1)
- in vitro intestinal model (1)
- incident type 2 diabetes (1)
- infection (1)
- inhibitory cytokines (1)
- insect proteins (1)
- insulin resistance (1)
- interleukin-35 (1)
- interleukin-8 (1)
- interventions (1)
- intestinal mucins (1)
- intestinal zinc resorption (1)
- ion-exchange chromatography (1)
- ionophore antibiotics (1)
- langsame und schnelle Fasertypen (1)
- later health (1)
- leucine (1)
- lineage commitment (1)
- lipids (1)
- liver toxicity (1)
- loci (1)
- lung inflammation (1)
- lymphopenia (1)
- lysosomal hydrolases (1)
- lysosome (1)
- lysozyme (1)
- lysozyme activity (1)
- macrophages (1)
- maintenance of genomic integrity (1)
- malnutrition (1)
- manganese (1)
- mass index (1)
- mass spectrometry (1)
- meal timing (1)
- mealworm (1)
- melatonin (1)
- membrane fusion (1)
- metabolic syndrome (1)
- metabolomics (1)
- methyl jasmonate (1)
- miRNAs (1)
- microcomputed tomography (1)
- micronutrients (1)
- microparticle (1)
- mitochondria, (1)
- mixtures (1)
- molecular pathways (1)
- morpholino analogues of fingolimod (1)
- mucus layer (1)
- multiple sclerosis (1)
- muscle (1)
- muscle fibre composition (1)
- myokine (1)
- myopathy (1)
- nanogels (1)
- native American ancestry (1)
- neurodegenerative diseases (1)
- nutrient transport (1)
- obesity (1)
- older persons (1)
- organic compounds adsorption (1)
- ovarian cancer (1)
- overweight (1)
- oxidative stress (1)
- p53 (1)
- parchment (1)
- patterns (1)
- phagocytosis (1)
- phthalates (1)
- physical activity (1)
- plasma (1)
- plasma measurements (1)
- platelets (1)
- poly(ADP-ribosyl)ation (1)
- polyphenols (1)
- population-specific risk marker (1)
- prediction (1)
- pregnancy (1)
- pregnane X-receptor (1)
- presystemic metabolism (1)
- proliferation (1)
- prostaglandin E2 (1)
- protein restriction (1)
- provitamin A (1)
- purification (1)
- rat (1)
- red wine (1)
- reliability (1)
- repeated measures design (1)
- repetitive elements (1)
- reproducibility (1)
- resistin (1)
- reversed-phase chromatography (1)
- risk (1)
- risk factors (1)
- sFlt-1 (1)
- salinomycin (1)
- saliva (1)
- salmon fish (1)
- scores (1)
- selenoneine (1)
- serine palmitoyltransferase (1)
- sex (1)
- size (1)
- skeletal muscle aging (1)
- skin penetration (1)
- slow and fast fiber types (1)
- spent coffee grounds (1)
- sphingolipid de novo synthesis (1)
- sphingomyelin (1)
- sphingosine (1)
- sphingosine kinase-1 (1)
- stable-isotope labeling (1)
- storage (1)
- suPAR (1)
- tacrolimus formulation (1)
- targeted metabolomics (1)
- tea processing (1)
- therapy (1)
- tocopherols (1)
- total phenol content (1)
- transformation product (1)
- transfusion-related acute lung injury (1)
- triazole fungicides (1)
- type 2 (1)
- ubiquitin proteasomal system (1)
- ultra-high performance liquid chromatography-mass spectrometry (UHPLC-MS) (1)
- validity (1)
- valine (1)
- valorization (1)
- variants (1)
- visfatin (1)
- volatile compounds (1)
- weight loss intervention (1)
- wheat (1)
- zinc (1)
- zinc binding (1)
Institute
- Institut für Ernährungswissenschaft (117) (remove)
Growth differentiation factor 15 (GDF15) is a cytokine best known for affecting systemic energy metabolism through its anorectic action. GDF15 expression and secretion from various organs and tissues is induced in different physiological and pathophysiological states, often linked to mitochondrial stress, leading to highly variable circulating GDF15 levels.
In skeletal muscle and the heart, the basal expression of GDF15 is very low compared to other organs, but GDF15 expression and secretion can be induced in various stress conditions, such as intense exercise and acute myocardial infarction, respectively. GDF15 is thus considered as a myokine and cardiokine. GFRAL, the exclusive receptor for GDF15, is expressed in hindbrain neurons and activation of the GDF15-GFRAL pathway is linked to an increased sympathetic outflow and possibly an activation of the hypothalamic-pituitary-adrenal (HPA) stress axis.
There is also evidence for peripheral, direct effects of GDF15 on adipose tissue lipolysis and possible autocrine cardiac effects. Metabolic and behavioral outcomes of GDF15 signaling can be beneficial or detrimental, likely depending on the magnitude and duration of the GDF15 signal.
This is especially apparent for GDF15 production in muscle, which can be induced both by exercise and by muscle disease states such as sarcopenia and mitochondrial myopathy.
Deep lipidomics in human plasma: cardiometabolic disease risk and effect of dietary fat modulation
(2022)
Background: In blood and tissues, dietary and endogenously generated fatty acids (FAs) occur in free form or as part of complex lipid molecules that collectively represent the lipidome of the respective tissue. We assessed associations of plasma lipids derived from high-resolution lipidomics with incident cardiometabolic diseases and subsequently tested if the identified risk-associated lipids were sensitive to dietary fat modification. Methods: The EPIC Potsdam cohort study (European Prospective Investigation into Cancer and Nutrition) comprises 27 548 participants recruited within an age range of 35 to 65 years from the general population around Potsdam, Germany. We generated 2 disease-specific case cohorts on the basis of a fixed random subsample (n=1262) and all respective cohort-wide identified incident primary cardiovascular disease (composite of fatal and nonfatal myocardial infarction and stroke; n=551) and type 2 diabetes (n=775) cases. We estimated the associations of baseline plasma concentrations of 282 class-specific FA abundances (calculated from 940 distinct molecular species across 15 lipid classes) with the outcomes in multivariable-adjusted Cox models. We tested the effect of an isoenergetic dietary fat modification on risk-associated lipids in the DIVAS randomized controlled trial (Dietary Intervention and Vascular Function; n=113). Participants consumed either a diet rich in saturated FAs (control), monounsaturated FAs, or a mixture of monounsaturated and n-6 polyunsaturated FAs for 16 weeks. Results: Sixty-nine lipids associated (false discovery rate<0.05) with at least 1 outcome (both, 8; only cardiovascular disease, 49; only type 2 diabetes, 12). In brief, several monoacylglycerols and FA16:0 and FA18:0 in diacylglycerols were associated with both outcomes; cholesteryl esters, free fatty acids, and sphingolipids were largely cardiovascular disease specific; and several (glycero)phospholipids were type 2 diabetes specific. In addition, 19 risk-associated lipids were affected (false discovery rate<0.05) by the diets rich in unsaturated dietary FAs compared with the saturated fat diet (17 in a direction consistent with a potential beneficial effect on long-term cardiometabolic risk). For example, the monounsaturated FA-rich diet decreased diacylglycerol(FA16:0) by 0.4 (95% CI, 0.5-0.3) SD units and increased triacylglycerol(FA22:1) by 0.5 (95% CI, 0.4-0.7) SD units. Conclusions: We identified several lipids associated with cardiometabolic disease risk. A subset was beneficially altered by a dietary fat intervention that supports the substitution of dietary saturated FAs with unsaturated FAs as a potential tool for primary disease prevention.
Aging is associated with bone loss, which can lead to osteoporosis and high fracture risk. This coincides with the enhanced formation of bone marrow adipose tissue (BMAT), suggesting a negative effect of bone marrow adipocytes on skeletal health. Increased BMAT formation is also observed in pathologies such as obesity, type 2 diabetes and osteoporosis. However, a subset of bone marrow adipocytes forming the constitutive BMAT (cBMAT), arise early in life in the distal skeleton, contain high levels of unsaturated fatty acids and are thought to provide a physiological function. Regulated BMAT (rBMAT) forms during aging and obesity in proximal regions of the bone and contain a large proportion of saturated fatty acids. Paradoxically, BMAT accumulation is also enhanced during caloric restriction (CR), a life-span extending dietary intervention. This indicates, that different types of BMAT can form in response to opposing nutritional stimuli with potentially different functions.
To this end, two types of nutritional interventions, CR and high fat diet (HFD), that are both described to induce BMAT accumulation were carried out. CR markedly increased BMAT formation in the proximal tibia and led to a higher proportion of unsaturated fatty acids, making it similar to the physiological cBMAT. Additionally, proximal and diaphyseal tibia regions displayed higher adiponectin expression. In aged mice, CR was associated with an improved trabecular bone structure. Taken together, these findings demonstrate, that the type of BMAT that forms during CR might provide beneficial effects for local bone stem/progenitor cells and metabolic health. The HFD intervention performed in this thesis showed no effect on BMAT accumulation and bone microstructure. RNA Seq analysis revealed alterations in the composition of the collagen-containing extracellular matrix (ECM).
In order to investigate the effects of glucose homeostasis on osteogenesis, differentiation capacity of immortalized multipotent mesenchymal stromal cells (MSCs) and osteochondrogenic progenitor cells (OPCs) was analyzed. Insulin improved differentiation in both cell types, however, combination of with a high glucose concentration led to an impaired mineralization of the ECM. In the MSCs, this was accompanied by the formation of adipocytes, indicating negative effects of the adipocytes formed during hyperglycemic conditions on mineralization processes. However, the altered mineralization pattern and structure of the ECM was also observed in OPCs, which did not form any adipocytes, suggesting further negative effects of a hyperglycemic environment on osteogenic differentiation.
In summary, the work provided in this thesis demonstrated that differentiation commitment of bone-resident stem cells can be altered through nutrient availability, specifically glucose. Surprisingly, both high nutrient supply, e.g. the hyperglycemic cell culture conditions, and low nutrient supply, e.g. CR, can induce adipogenic differentiation. However, while CR-induced adipocyte formation was associated with improved trabecular bone structure, adipocyte formation in a hyperglycemic cell-culture environment hampered mineralization. This thesis provides further evidence for the existence of different types of BMAT with specific functions.
The aim of this study was to assess the ability of the FFQ to describe reliable and valid dietary pattern (DP) scores. In a total of 134 participants of the European Prospective Investigation into Cancer and Nutrition-Potsdam study aged 35-67 years, the FFQ was applied twice (baseline and after 1 year) to assess its reliability. Between November 1995 and March 1997, twelve 24-h dietary recalls (24HDR) as reference instrument were applied to assess the validity of the FFQ. Exploratory DP were derived by principal component analyses. Investigated predefined DP were the Alternative Healthy Eating Index (AHEI) and two Mediterranean diet indices. From dietary data of each FFQ, two exploratory DP were retained, but differed in highly loading food groups, resulting in moderate correlations (r 0 center dot 45-0 center dot 58). The predefined indices showed higher correlations between the FFQ (r(AHEI) 0 center dot 62, r(Mediterranean Diet Pyramid Index (MedPyr)) 0 center dot 62 and r(traditional Mediterranean Diet Score (tMDS)) 0 center dot 51). From 24HDR dietary data, one exploratory DP retained differed in composition to the first FFQ-based DP, but showed similarities to the second DP, reflected by a good correlation (r 0 center dot 70). The predefined DP correlated moderately (r 0 center dot 40-0 center dot 60). To conclude, long-term analyses on exploratory DP should be interpreted with caution, due to only moderate reliability. The validity differed extensively for the two exploratory DP. The investigated predefined DP showed a better reliability and a moderate validity, comparable to other studies. Within the two Mediterranean diet indices, the MedPyr performed better than the tMDs in this middle-aged, semi-urban German study population.
Current attempts to prevent and manage type 2 diabetes have been moderately effective, and a better understanding of the molecular roots of this complex disease is important to develop more successful and precise treatment options.
Recently, we initiated the collective diabetes cross, where four mouse inbred strains differing in their diabetes susceptibility were crossed with the obese and diabetes-prone NZO strain and identified the quantitative trait loci (QTL) Nidd13/NZO, a genomic region on chromosome 13 that correlates with hyperglycemia in NZO allele carriers compared to B6 controls.
Subsequent analysis of the critical region, harboring 644 genes, included expression studies in pancreatic islets of congenic Nidd13/NZO mice, integration of single-cell data from parental NZO and B6 islets as well as haplotype analysis.
Finally, of the five genes (Acot12, S100z, Ankrd55, Rnf180, and Iqgap2) within the polymorphic haplotype block that are differently expressed in islets of B6 compared to NZO mice, we identified the calcium-binding protein S100z gene to affect islet cell proliferation as well as apoptosis when overexpressed in MINE cells. In summary, we define S100z as the most striking gene to be causal for the diabetes QTL Nidd13/NZO by affecting beta-cell proliferation and apoptosis. Thus, S100z is an entirely novel diabetes gene regulating islet cell function.
Insulin is the main anabolic hormone secreted by 13-cells of the pancreas stimulating the assimilation and storage of glucose in muscle and fat cells. It modulates the postprandial balance of carbohydrates, lipids and proteins via enhancing lipogenesis, glycogen and protein synthesis and suppressing glucose generation and its release from the liver. Resistance to insulin is a severe metabolic disorder related to a diminished response of peripheral tissues to the insulin action and signaling. This leads to a disturbed glucose homeostasis that precedes the onset of type 2 diabetes (T2D), a disease reaching epidemic proportions. A large number of studies reported an association between elevated circulating fatty acids and the development of insulin resistance. The increased fatty acid lipid flux results in the accumulation of lipid droplets in a variety of tissues. However, lipid intermediates such as diacylglycerols and ceramides are also formed in response to elevated fatty acid levels. These bioactive lipids have been associated with the pathogenesis of insulin resistance. More recently, sphingosine 1-phosphate (S1P), another bioactive sphingolipid derivative, has also been shown to increase in T2D and obesity. Although many studies propose a protective role of S1P metabolism on insulin signaling in peripheral tissues, other studies suggest a causal role of S1P on insulin resistance. In this review, we critically summarize the current state of knowledge of S1P metabolism and its modulating role on insulin resistance. A particular emphasis is placed on S1P and insulin signaling in hepatocytes, skeletal muscle cells, adipocytes and pancreatic 13-cells. In particular, modulation of receptors and enzymes that regulate S1P metabolism can be considered as a new therapeutic option for the treatment of insulin resistance and T2D.
Being born large for gestational age is associated with increased global placental DNA methylation
(2020)
Being born small (SGA) or large for gestational age (LGA) is associated with adverse birth outcomes and metabolic diseases in later life of the offspring. It is known that aberrations in growth during gestation are related to altered placental function. Placental function is regulated by epigenetic mechanisms such as DNA methylation. Several studies in recent years have demonstrated associations between altered patterns of DNA methylation and adverse birth outcomes. However, larger studies that reliably investigated global DNA methylation are lacking. The aim of this study was to characterize global placental DNA methylation in relationship to size for gestational age. Global DNA methylation was assessed in 1023 placental samples by LC-MS/MS. LGA offspring displayed significantly higher global placental DNA methylation compared to appropriate for gestational age (AGA; p<0.001). ANCOVA analyses adjusted for known factors impacting on DNA methylation demonstrated an independent association between placental global DNA methylation and LGA births (p<0.001). Tertile stratification according to global placental DNA methylation levels revealed a significantly higher frequency of LGA births in the third tertile. Furthermore, a multiple logistic regression analysis corrected for known factors influencing birth weight highlighted an independent positive association between global placental DNA methylation and the frequency of LGA births (p=0.001).
Macrophages have important protective functions during infection with herpes simplex virus type 1 (HSV-1). However, molecular mechanisms that restrict viral propagation and protect from severe disease are unclear. Here we show that macrophages take up HSV-1 via endocytosis and transport the virions into multivesicular bodies (MVBs). In MVBs, acid ceramidase (aCDase) converts ceramide into sphingosine and increases the formation of sphingosine-rich intraluminal vesicles (ILVs). Once HSV-1 particles reach MVBs, sphingosine-rich ILVs bind to HSV-1 particles, which restricts fusion with the limiting endosomal membrane and prevents cellular infection. Lack of aCDase in macrophage cultures or in Asah1(-/-) mice results in replication of HSV-1 and Asah1(-/-) mice die soon after systemic or intravaginal inoculation. The treatment of macrophages with sphingosine enhancing compounds blocks HSV-1 propagation, suggesting a therapeutic potential of this pathway. In conclusion, aCDase loads ILVs with sphingosine, which prevents HSV-1 capsids from penetrating into the cytosol.
Experimental studies have reported on the anti-inflammatory properties of polyphenols. However, results from epidemiological investigations have been inconsistent and especially studies using biomarkers for assessment of polyphenol intake have been scant. We aimed to characterise the association between plasma concentrations of thirty-five polyphenol compounds and low-grade systemic inflammation state as measured by high-sensitivity C-reactive protein (hsCRP). A cross-sectional data analysis was performed based on 315 participants in the European Prospective Investigation into Cancer and Nutrition cohort with available measurements of plasma polyphenols and hsCRP. In logistic regression analysis, the OR and 95 % CI of elevated serum hsCRP (>3 mg/l) were calculated within quartiles and per standard deviation higher level of plasma polyphenol concentrations. In a multivariable-adjusted model, the sum of plasma concentrations of all polyphenols measured (per standard deviation) was associated with 29 (95 % CI 50, 1) % lower odds of elevated hsCRP. In the class of flavonoids, daidzein was inversely associated with elevated hsCRP (OR 0 center dot 66, 95 % CI 0 center dot 46, 0 center dot 96). Among phenolic acids, statistically significant associations were observed for 3,5-dihydroxyphenylpropionic acid (OR 0 center dot 58, 95 % CI 0 center dot 39, 0 center dot 86), 3,4-dihydroxyphenylpropionic acid (OR 0 center dot 63, 95 % CI 0 center dot 46, 0 center dot 87), ferulic acid (OR 0 center dot 65, 95 % CI 0 center dot 44, 0 center dot 96) and caffeic acid (OR 0 center dot 69, 95 % CI 0 center dot 51, 0 center dot 93). The odds of elevated hsCRP were significantly reduced for hydroxytyrosol (OR 0 center dot 67, 95 % CI 0 center dot 48, 0 center dot 93). The present study showed that polyphenol biomarkers are associated with lower odds of elevated hsCRP. Whether diet rich in bioactive polyphenol compounds could be an effective strategy to prevent or modulate deleterious health effects of inflammation should be addressed by further well-powered longitudinal studies.
Background: Dietary protein restriction is emerging as an alternative approach to treat obesity and glucose intolerance because it markedly increases plasma fibroblast growth factor 21 (FGF21) concentrations. Similarly, dietary restriction of methionine is known to mimic metabolic effects of energy and protein restriction with FGF21 as a required mechanism. However, dietary protein has been shown to be required for normal bone growth, though there is conflicting evidence as to the influence of dietary protein restriction on bone remodeling. The purpose of the current study was to evaluate the effect of dietary protein and methionine restriction on bone in lean and obese mice, and clarify whether FGF21 and general control nonderepressible 2 (GCN2) kinase, that are part of a novel endocrine pathway implicated in the detection of protein restriction, influence the effect of dietary protein restriction on bone.
Methods: Adult wild-type (WT) or Fgf21 KO mice were fed a normal protein (18 kcal%; CON) or low protein (4 kcal%; LP) diet for 2 or 27 weeks. In addition, adult WT or Gcn2 KO mice were fed a CON or LP diet for 27 weeks. Young New Zealand obese (NZO) mice were placed on high-fat diets that provided protein at control (16 kcal%; CON), low levels (4 kcal%) in a high-carbohydrate (LP/HC) or high-fat (LP/HF) regimen, or on high-fat diets (protein, 16 kcal%) that provided methionine at control (0.86%; CON-MR) or low levels (0.17%; MR) for up to 9 weeks. Long bones from the hind limbs of these mice were collected and evaluated with micro-computed tomography (mu CT) for changes in trabecular and cortical architecture and mass.
Results: In WT mice the 27-week LP diet significantly reduced cortical bone, and this effect was enhanced by deletion of Fgf21 but not Gcn2. This decrease in bone did not appear after 2 weeks on the LP diet. In addition, Fgf21 KO mice had significantly less bone than their WT counterparts. In obese NZO mice dietary protein and methionine restriction altered bone architecture. The changes were mediated by FGF21 due to methionine restriction in the presence of cystine, which did not increase plasma FGF21 levels and did not affect bone architecture.
Conclusions: This study provides direct evidence of a reduction in bone following long-term dietary protein restriction in a mouse model, effects that appear to be mediated by FGF21.